SER120

DRUG3 trials

Sponsors

Serenity Pharmaceuticals, Inc.

Conditions

Nocturia

Phase 3

Treatment of Patients With Nocturia

CompletedNCT00937859

Serenity Pharmaceuticals, Inc.Nocturia

Start: 2009-06-30End: 2010-07-31Updated: 2020-09-18

Treatment of Patients With Nocturia (Non-PK Study)

CompletedNCT00937378

Serenity Pharmaceuticals, Inc.Nocturia

Start: 2009-06-30End: 2010-08-31Updated: 2020-10-22

Long Term Safety Assessment of SER120 in Patients With Nocturia

CompletedNCT00981682

Serenity Pharmaceuticals, Inc.Nocturia

Start: 2009-08-31End: 2011-08-31Updated: 2021-01-20